ОТВЕТНАЯ РЕАКЦИЯ ТОНКОЙ КИШКИ НА ЭКСПЕРИМЕНТАЛЬНЫЙ ФИБРОЗ ЛЕГКИХ

Авторы

  • ХАСАНОВА Дилноза Ахроровна
  • БАРНОЕВ Ахтам Истамович

Ключевые слова:

12-перстная, тощая и подвздошная кишка, слизистая оболочка, фиброз лёгких

Аннотация

Экспериментальное исследование было проведено на 120 крысах-самцах. Показана динамика изменения морфометрических показателей толщины слизистой оболочки тонкой кишки. При экспериментальном лёгочном фиброзе животных наблюдались изменения в морфометрических показателях. Показатели слизистой оболочки 12 перстной и тощей кишки увеличились на 5 сутки до значения контрольной группы через 30 дней эксперимента. В подвздошном кишечнике показатели не увеличивались до 5-го дня эксперимента.

Библиографические ссылки

Davlatova I.S., Naumova L.I., Shishkina T.A. Reactivity of the intestinal epithelium against the background of hypoxia of different genesis. //Topical issues of modern medicine: Materials of the IV International Scientific and Practical Conference of the Caspian States. Astrakhan. 2019; 274–6. (in Russ).

Denisenko Yu.K., Novgorodtseva T.P., Vitkina T.I., Antonyuk M.V., Zhukova N.V. On the issue of mitochondrial dysfunction in chronic obstructive pulmonary disease // Bulletin of physiology and pathology of respiration, 2016. Issue 60. pp. 28-33. (in Russ).

Dolgushin I.I., Mezentseva E.A., Savochkina A.Yu., Kuznetsova E.K. Neutrophil as a "multifunctional device" of the immune system // Infection and Immunity, 2019. Vol. 9, No. 1. pp. 9-38. (in Russ).

Evseeva G.P., Knizhnikova E.V., Suprun E.N., Suprun S.V., Kuderova N.I., Pichugina S.V., Polubartseva V.V., Evdokimova T.S., Lebedko O.A. Features of the membrane potential of mitochondria of immunocompetent blood cells in children with chronic nonspecific lung diseases accompanied by the phenomena of pneumofibrosis. Medical immunology. 2022;24(1):187-194. (in Russ).

Evseeva G.P., Yakovlev E.I., Lebedko O.A., Kuznetsova M.S., Pichugina S.V., Kuderova N.I., Sirina T.S., Varakina V.L., Kozlov V.K. Diagnostics of energy-deficient conditions in children with chronic bronchopulmonary pathology // Bulletin of physiology and pathology of respiration, 2018. Issue. 68. pp. 46-51. (in Russ).

Ignatovich T.V., Zafranskaya M.M. Immunopathogenesis of fibrosis // Immunopathology, allergology, infectology, 2019. No. 1. pp. 6-17. (in Russ).

Lebedeva A.I., Muslimov S.A., Musina L.A. Experimental modeling of the process of chronic inflammation and fibrosis // Biomedicine, 2013. No. 4. pp. 114-123. (in Russ).

Savchenko A.A., Borisov A.G., Modestov A.A., Moshev A.V., Kudryavtsev I.V., Tonacheva O.G., Kosheev V.N. Phenotypic composition and chemiluminescent activity of monocytes in patients with renal cell carcinoma // Medical Immunology, 2015. Vol. 17, No. 2. pp. 141-150. (in Russ).

Frelich G.A., Folomeeva N.Yu., Vasiliev A.S., Udut V.V. Modern methods for assessing the functional state of mitochondria // Siberian Journal of Clinical and Experimental Medicine, 2013. Vol. 28, No. 3. pp. 7-13. (in Russ).

Khorenko A.V., Amarantov D.G., Kosareva P.V. The role of violation of cell-matrix interactions in the pathogenesis of lung fibrosis progression // Journal of Anatomy and Histopathology, 2016. Vol. 5, No. 3. pp. 84-89. (in Russ).

Aravamudan B., Thompson M.A., Pabelick C.M., Prakash Y.S. Mitochondria in lung diseases. Expert Rev. Respir. Med., 2013, Vol. 7, no. 5. pp. 631-646.

Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016;16(1):51–67.

da Rocha Lapa F, da Silva MD, de Almeida Cabrini D, Santos AR. Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors. Purinergic Signal., 2012, Dec., vol. 8, no. 4, pp. 693-704.

Dalli J, Vlasakov I, Riley IR, et al. Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages. Proc Natl Acad Sci U S A. 2016;113(43):12232–12237.

Datta A., Scotton C.J., Chambers R.C. Novel therapeutic approaches for pulmonary fibrosis // British Journal of Pharmacology. - 2011. - Vol. 163. -P. 141 - 172.

Han J, Li H, Bhandari S, et al. Maresin conjugates in tissue regeneration 1 improves alveolar fluid clearance by up-regulating alveolar ENaC, Na, K-ATPase in lipopolysaccharide-induced acute lung injury. J Cell Mol Med. 2020;24(8):4736–4747.

Li H, Hao Y, Yang LL, et al. MCTR1 alleviates lipopolysaccharide-induced acute lung injury by protecting lung endothelial glycocalyx. J Cell Physiol. 2020;235(10):7283–7294.

Maher TM, Wuyts W. Management of fibrosing interstitial lung diseases. Adv Ther. 2019;36(7):1518–1531.

Meyer KC. Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med. 2017;11(5):343–359.

Pan J, Li X, Wang X, Yang L, Chen H, Su N, Wu C, Hao Y , Jin S , Li H //MCTR1 Intervention Reverses Experimental Lung Fibrosis in Mice/Volume 2021:14 Pages 1873—1881

Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941–1952.

Rakhimov N.M., Khudayberdiyeva Sh.A., Oripova M.R., Shakhanova Sh.Sh. Practical recommendations for Nutritional support for cervical cancer// Journal of Biomedicine and Practice. 2023, vol. 8, issue 2,pp.224-230

Sabharwal S. «Gastrointestinal Manifestations of Cystic Fibrosis» Gastroenterol Hepatol (N Y). 2016 Jan; 12(1): 43–47.

Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27(3):200–215.

Sheikh SI, Ryan-Wenger NA, McCoy KS. Outcomes of surgical management of severe GERD in patients with cystic fibrosis. Pediatr Pulmonol. 2013;48(6):556–562.

Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383(10):958–968.

Yang Y, Zhu Y, Xiao J, et al. Maresin conjugates in tissue regeneration 1 prevents lipopolysaccharide-induced cardiac dysfunction through improvement of mitochondrial biogenesis and function. Biochem Pharmacol. 2020;177:11-40.

Статья поступила в редакцию 04.11.2023; одобрена после рецензирования 23.12.2023; принята к публикации 25.12.2023.

The article was submitted 04.11.2023; approved after reviewing 23.12.2023; accepted for publication 25.12.2023.

Информация об авторах:

Хасанова Дилноза Ахроровна- д.м.н., доцент, декан международного факультета. Бухарский государственный медицинский институт, Бухара, Узбекистан. Е-mail: akwamarin80@gmail.com, https://orcid.org/0000-0003-0433-0747

Барноев Ахтам Истамович- самостоятельный соискатель кафедры анатомии, клинической анатомии (ОХТА). Бухарский государственный медицинский институт, Бухара, Узбекистан. Е-mail: govinda2006@yandex.ru, https://orcid.org/0000-0003-2945-8550

Источники финансирования: Работа не имела специального финансирования.

Конфликт интересов: Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.

Вклад авторов:

Хасанова Д.А. — идеологическая концепция работы, написание текста; редактирование статьи; Барноев А.И. — сбор и анализ источников литературы, написание текста.

Information about the authors:

Dilnoza A. Khasanova — DSc, associate professor, dean of international faculty Bukhara state medical istitute. Bukhara, Uzbekistan; E-mail: akwamarin80@gmail.com, https://orcid.org/0000-0003-0433-0747

Ahtam I. Barnoev — independent candidate of the Department of Anatomy, Clinical Anatomy (OHTA). Bukhara State Medical Institute, Bukhara, Uzbekistan; Е-mail: govinda2006@yandex.ru, https://orcid.org/0000-0003-2945-8550

Sources of funding: The work did not receive any specific funding.

Conflict of interest: The authors declare no explicit or potential conflicts of interest associated with the publication of this article.

Contribution of the authors:

Khasanova D.A. — ideological concept of the work, writing the text; editing the article;

Barnoev A.I. — collection and analysis of literature sources, writing the text.

Загрузки

Опубликован

2024-01-26